tubercidin has been researched along with Cerebral Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DaRe, J; Foster, AC; Jelovich, LA; Miller, LP; Ugarkar, B; Yao, L | 1 |
| Chopp, M; Jiang, N; Kowaluk, EA; Lee, CH; Mazdiyasni, H | 1 |
2 other study(ies) available for tubercidin and Cerebral Infarction
| Article | Year |
|---|---|
Pre- and peristroke treatment with the adenosine kinase inhibitor, 5'-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats.
Topics: Adenosine Kinase; Animals; Cerebral Arteries; Cerebral Infarction; Cerebrovascular Disorders; Constriction, Pathologic; Male; Rats; Tubercidin | 1996 |
Adenosine kinase inhibition protects brain against transient focal ischemia in rats.
Topics: Adenosine Kinase; Animals; Arterial Occlusive Diseases; Body Temperature; Body Weight; Brain; Cerebral Infarction; Enzyme Inhibitors; Ischemic Attack, Transient; Male; Neuroprotective Agents; Rats; Rats, Wistar; Tubercidin | 1997 |